11-34113737-A-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_024662.3(NAT10):āc.394A>Gā(p.Asn132Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,648 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 31)
Exomes š: 0.000023 ( 0 hom. )
Consequence
NAT10
NM_024662.3 missense
NM_024662.3 missense
Scores
11
4
4
Clinical Significance
Conservation
PhyloP100: 9.10
Genes affected
NAT10 (HGNC:29830): (N-acetyltransferase 10) The protein encoded by this gene is an RNA cytidine acetyltransferase involved in histone acetylation, tRNA acetylation, the biosynthesis of 18S rRNA, and the enhancement of nuclear architecture and chromatin organization. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.976
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAT10 | NM_024662.3 | c.394A>G | p.Asn132Asp | missense_variant | 5/29 | ENST00000257829.8 | NP_078938.3 | |
NAT10 | NM_001144030.2 | c.178A>G | p.Asn60Asp | missense_variant | 3/27 | NP_001137502.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAT10 | ENST00000257829.8 | c.394A>G | p.Asn132Asp | missense_variant | 5/29 | 1 | NM_024662.3 | ENSP00000257829 | P1 | |
NAT10 | ENST00000531159.6 | c.178A>G | p.Asn60Asp | missense_variant | 3/27 | 2 | ENSP00000433011 | |||
NAT10 | ENST00000527971.5 | c.394A>G | p.Asn132Asp | missense_variant | 4/8 | 2 | ENSP00000437324 | |||
NAT10 | ENST00000529523.5 | c.394A>G | p.Asn132Asp | missense_variant | 5/5 | 4 | ENSP00000435569 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151974Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
5
AN:
151974
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251294Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135836
GnomAD3 exomes
AF:
AC:
5
AN:
251294
Hom.:
AF XY:
AC XY:
4
AN XY:
135836
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000226 AC: 33AN: 1461674Hom.: 0 Cov.: 34 AF XY: 0.0000234 AC XY: 17AN XY: 727152
GnomAD4 exome
AF:
AC:
33
AN:
1461674
Hom.:
Cov.:
34
AF XY:
AC XY:
17
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151974Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74204
GnomAD4 genome
AF:
AC:
5
AN:
151974
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74204
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.394A>G (p.N132D) alteration is located in exon 5 (coding exon 4) of the NAT10 gene. This alteration results from a A to G substitution at nucleotide position 394, causing the asparagine (N) at amino acid position 132 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Intellectual disability Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Feb 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
D;D;D;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
D;.;.;.
Vest4
MutPred
Loss of catalytic residue at N132 (P = 0.0822);.;Loss of catalytic residue at N132 (P = 0.0822);Loss of catalytic residue at N132 (P = 0.0822);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at